XML 78 R67.htm IDEA: XBRL DOCUMENT v3.26.3
Notes Payable - 2025 March Unsecured SPA Notes Narrative (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
May 28, 2025
$ / shares
Mar. 21, 2025
USD ($)
day
closing
$ / shares
Sep. 30, 2026
USD ($)
$ / shares
shares
Sep. 30, 2025
USD ($)
shares
Sep. 30, 2026
USD ($)
$ / shares
shares
Sep. 30, 2025
USD ($)
shares
Sep. 24, 2026
$ / shares
Sep. 22, 2026
$ / shares
Aug. 31, 2026
USD ($)
Aug. 20, 2026
USD ($)
shares
Jun. 30, 2026
USD ($)
Dec. 31, 2025
USD ($)
$ / shares
Aug. 14, 2025
$ / shares
Jun. 30, 2025
USD ($)
May 15, 2025
$ / shares
Dec. 31, 2024
USD ($)
Class A Common Stock                                
Debt Instrument [Line Items]                                
Share price (in dollars per share) | $ / shares                       $ 153.00 $ 450.00      
Exercise price (in dollars per share) | $ / shares     $ 72,066   $ 72,066                      
2025 March Unsecured SPA Notes                                
Debt Instrument [Line Items]                                
Debt instrument, term         5 years                      
Percent of purchaser's conversion shares     100.00%   100.00%                      
2025 March Unsecured SPA Notes                                
Debt Instrument [Line Items]                                
Notes payable bearing interest rate   10.00%                            
Redemption price, percentage   25.00%                            
Notes Payable                                
Debt Instrument [Line Items]                                
Notes and loans payable     $ 80,198 $ 78,902 $ 80,198 $ 78,902         $ 99,928 $ 60,666   $ 28,033   $ 49,488
Gain (loss) on fair value adjustment of debts     $ 8,827 18,074 $ 6,660 31,131                    
Notes Payable | 2025 March Unsecured SPA Notes                                
Debt Instrument [Line Items]                                
Aggregate principal amount   $ 41,000                            
Debt instrument, number of closings | closing   4                            
Debt instrument, term   5 years     5 years                      
Notes payable bearing interest rate   18.00% 10.00%   10.00%             10.00%        
Debt instrument, redemption price, percentage   10.00%                            
Redemption price, percentage   8.00%                            
Conversion price (in dollars per share) | $ / shares $ 183.00 $ 193.50                            
Debt instrument, convertible, threshold consecutive trading days | day   5                            
Debt instrument, floor price (in dollars per share) | $ / shares     $ 5.00   $ 5.00   $ 1.00 $ 1.50                
Debt instrument, SPA waiver, term                             45 days  
Debt instrument, SPA waiver, deferral period                             20 days  
Share price (in dollars per share) | $ / shares                             $ 1.00  
Debt instrument, convertible, threshold percentage of stock price trigger 100.00%                              
Debt instrument, exercisable, threshold percentage of stock price trigger 120.00%                              
Exercise price (in dollars per share) | $ / shares $ 219.60                              
Notes and loans payable     $ 2,250 7,211 $ 2,250 7,211         $ 3,373 $ 2,108   $ 9,297   $ 0
Proceeds from debt, net of issuance costs     1,000 8,100 5,700 32,200                    
Debt conversion, converted amount     $ 0 $ 9,300 $ 1,700 $ 16,000                    
Shares issued from conversion (in shares) | shares     0 56,195 12,252 97,326                    
Loss on extinguishment of debt     $ 0 $ 9,800 $ 1,300 $ 15,300                    
Gain (loss) on fair value adjustment of debts     $ 1,510 $ 2,987 $ 1,492 $ 274                    
Notes Payable | 2025 March Unsecured SPA Notes | Series B Preferred Stock                                
Debt Instrument [Line Items]                                
Pro rata aggregate cap (in shares) | shares     9,000,000   9,000,000                      
Notes Payable | 2025 March Unsecured SPA Notes | 2025 March Unsecured SPA Notes                                
Debt Instrument [Line Items]                                
Aggregate principal amount                 $ 21,000 $ 8,500            
Notes Payable | 2025 March Unsecured SPA Notes | Common Stock Warrants | Class A Common Stock                                
Debt Instrument [Line Items]                                
Warrants rights (in shares) | shares                   46,659